Astrana Health IncASTH
Price$35.57Intrinsic value$94.48166% above price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $94.48median of 6 methods · middle span $36-$313based on filings through 30 Jun 2026
Market Price $35.57Price as of 30 Sep 2026
Margin of Safety +165.6%as of 30 Sep 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 5.0% (near-term consensus, capped) · years 2–5: 77.8%/yr (balance of the path).60.0% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 662.8%Yr 747.9%Yr 832.9%Yr 918.0%Yr 103.0%
77.8% → 3.0%
Years 11–20: glide to long-run rate
Per-year rates
Yr 113.0%Yr 123.0%Yr 133.0%Yr 143.0%Yr 153.0%Yr 163.0%Yr 173.0%Yr 183.0%Yr 193.0%Yr 203.0%
3.0% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Historical EPS growth (multi-year median)median of 3 windows (5/6/7y)2.8%
Discount rate (cost of equity) 9.1%
Volatility vs market (adjusted beta)0.92

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetAstrana Health IncASTHHealth Care
Valuation
P/E43.4×
P/S0.4×
P/B2.1×
EV / Revenue0.6×
EV / EBITDA17.3×
Profitability
Gross margin10.7%
Operating margin2.5%
Net margin1.1%
FCF margin2.5%
Returns
ROE4.9%
ROA1.8%
ROIC3.0%
Growth
Revenue growth (YoY)88.9%
5-yr fwd EPS growth77.5%
Financial strength
Debt / Equity1.13×
Current ratio1.23×
Altman Z-Score2.8
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.